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of routine clinical care provided at a prenatal visit, a brief tobacco educational intervention for Alaska
Native pregnant women (N=100; mean ± SD age = 25.9±6.2 years; mean 6.3± 2.6 months gestation) was
piloted at the Y-K Delta Regional Hospital in Bethel, Alaska. This retrospective study reports on the
evaluation of this clinical program. The intervention was consistent with the clinical practice guidelines
(i.e., 5 A’s – ask, advise, assess, assist, arrange), with an average duration of 20.2 ± 6.8 minutes. The selfreported tobacco abstinence rate following the intervention was 11% at the last prenatal visit and 12% at
delivery. Delivering a tobacco cessation intervention at a prenatal visit is feasible, but there is a need to
identify more effective interventions for Alaska Native pregnant women.
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Abstract
Tobacco cessation interventions developed and evaluated for Alaska Native
women do not exist. As part of routine clinical care provided at a prenatal
visit, a brief tobacco educational intervention for Alaska Native pregnant
women (N=100; mean ± SD age = 25.9±6.2 years; mean 6.3± 2.6 months
gestation) was piloted at the Y-K Delta Regional Hospital in Bethel, Alaska.
This retrospective study reports on the evaluation of this clinical program.
The intervention was consistent with the clinical practice guidelines (i.e., 5 A’s
– ask, advise, assess, assist, arrange), with an average duration of 20.2 ± 6.8
minutes. The self-reported tobacco abstinence rate following the intervention was 11% at the last prenatal visit and 12% at delivery. Delivering a tobacco cessation intervention at a prenatal visit is feasible, but there is a need
to identify more effective interventions for Alaska Native pregnant women.
Key Words: Tobacco cessation, tobacco use, Alaska Native, pregnancy
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Introduction
Reducing tobacco use during pregnancy among Alaska Native women is
a national public health priority (Fiore et al., 2008). In 2000, cigarette smoking
during pregnancy was most prevalent among American Indian and Alaska
Native women (20%) followed by non-Hispanic Whites (16%), non-Hispanic
Blacks (9%) and Hispanic women (4%) (Martin, Hamilton, Ventura, Menacker,
& Park, 2002). Overall the percentage of U.S. women reporting smokeless
tobacco (ST) use during pregnancy is very low (<1%) (Substance Abuse and
Mental Health Services Administration, 2006). Among Alaska Native women
residing in the Yukon-Kuskokwim (Y-K) Delta of Western Alaska, between
76-79% use ST or smoke cigarettes during pregnancy (Hurt et al., 2005;
Patten et al., 2008 in press; Renner et al., 2004). However, tobacco cessation
interventions developed for Alaska Native women do not exist (Melvin &
Gaffney, 2004; USDHHS, 2001) Moreover, aside from our qualitative work
(Renner et al., 2004), health beliefs related to tobacco use during pregnancy
have not been assessed among Alaska Native women.
The most common form of ST used in Western Alaska is known as Iqmik, a
mixture of fire-cured tobacco leaves and fungus ash. Iqmik is most commonly
prepared by women, who mix the ash with tobacco leaves and then prechew it, or mix it in a bowl with water where it is cut and stirred with a knife.
Iqmik and other tobacco products are not used ceremonially by Alaska Native
people (Blanchette, 2001). Because of the high pH (10.9) of the fungus ash,
almost 100% of the nicotine in Iqmik is in the freebase form (Renner, Enoch
et al., 2005). This allows for rapid absorption of nicotine across the buccal
mucosal membrane, which likely contributes to the addictive properties of
Iqmik. Among 60 pregnant Alaska Native women of this region, we found
that those reporting only Iqmik use during the seven days prior to delivery
had significantly higher mean concentrations of cotinine in maternal blood
and infant cord blood compared with women who used other tobacco
products or reported abstinence from tobacco (Hurt et al., 2005). Our findings
also indicated that neonates born to mothers using only Iqmik experienced
greater adverse neurobehavioral effects (e.g., irritability) than the neonates
born to women who reported using other tobacco products or no tobacco
use. Nonetheless, our prior qualitative work suggests a lack of knowledge
about the potential health effects of Iqmik use during pregnancy (Renner et
al., 2004).
In samples of non-Alaska Native pregnant women who smoke cigarettes,
most are aware that smoking during pregnancy could be deleterious to the
outcome of their pregnancy (USDHHS, 2001), that is, between 68-75% report
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that smoking could have adverse pregnancy outcomes and 61-93% perceive
that smoking is harmful to the fetus (Arnold et al., 2001; Dunn, Pirie, & Lando,
1998; Gawley & Cupples, 2002; Lelong, Kaminski, Chwalow, Bean, & Subtil,
1995; Walsh, Redman, Brinsmead, & Fryer, 1997). Unfortunately, these health
beliefs are not highly correlated with smoking cessation during pregnancy
(Acharya, Jauniaux, Sathia, Griffin, & Morgan, 2002; Arnold et al., 2001; Haslam,
Draper, & Goyder, 1997). That is, most research indicates that the beliefs of
women who quit are similar to those who continue to smoke. However, some
studies suggest that continuing smokers are less likely to perceive adverse
health effects of smoking during pregnancy than women who stop smoking
(Haslam & Draper, 2000).
The state-of-the-art intervention for pregnant women (Windsor et al.,
2000) consists of a brief (5-minute) cessation counseling session delivered by
a trained provider and the provision of pregnancy specific, self-help materials.
There are five components (5A’s) of the recommended method: ask, advise,
assess, assist, and arrange (Fiore et al., 2008; Melvin et al., 2000). A metaanalysis performed of 34 intervention trials during pregnancy found the mean
rate of smoking cessation was 16% for intervention groups versus 9% for
control groups (Lumley, Oliver, Chamberlain, & Oakley, 2004).
Building on our successful partnership and previous work with the
Alaska Native community (Enoch & Patten, 2004; Renner, Enoch et al., 2005),
this retrospective study represents an initial step in developing targeted
tobacco cessation interventions for pregnant Alaska Native women. As part
of routine clinical care provided at the first prenatal visit, the Nicotine Control
and Research Program at the Y-K Delta Regional Hospital in Bethel, Alaska,
piloted a brief tobacco educational intervention for pregnant women. This
retrospective study reports on the evaluation of this clinical program. Our
aims were to: (1) describe the baseline (i.e., prior to the intervention) sociodemographics, tobacco use characteristics, and tobacco-related health beliefs;
(2) compare these baseline variables by type of tobacco used; and (3) examine
maternal tobacco use status following the educational intervention at the last
prenatal visit and at delivery.

Methods
This study was approved by the Yukon-Kuskokwim Health Corporation
(YKHC) Human Studies Committee and Board of Directors, Alaska Native Tribal
Health Consortium Board of Directors, Alaska Native Area Health Service IRB,
and the Mayo Clinic IRB.
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Study Design
A retrospective review of a clinical database and medical records was
performed. Counselors were trained on the delivery of the intervention and
data collection procedures. The intervention was piloted with 100 women
seen for prenatal care over a 10-month period in 2002. All intervention data
were entered by counselors into an electronic database. Obstetrical staff
routinely assesses tobacco use at the week 36 visit and at delivery and these
data are entered into the patient’s medical record.
Study Setting
The Y-K Delta covers an area in Western Alaska about the size of the
state of Ohio. The village of Bethel (population 6,000) is the regional
hub for the villages comprising Western Alaska. Approximately 94% of
the regional population outside of Bethel is made up of Alaska Native
people-- predominantly Yup’ik or Cup’ik. The Y-K Delta population of
25,000 is extremely young (current median age is 23.5 years), and with low
socioeconomic status (Alaska Humanities Forum, 2003). Most of the residents
live largely subsistence lifestyles, hunting and fishing and gathering berries
and plants, and receive some monetary assistance from the federal and state
governments. The 58 villages comprising the Y-K Delta are not linked by
road and are accessible only by boat, airplane, or snowmobile. The majority
of residents of this region receive their health care from the village based
community health aides and the Y-K Delta Regional Hospital located in Bethel,
AK. Multi-specialty tertiary care is available on referral to the Alaska Native
Medical Center in Anchorage. The Y-K Delta Regional Hospital is operated by
the YKHC, a tribally owned and operated health corporation with a Board of
elected members representing the communities within the region.
The Obstetrical Unit at the Bethel hospital is staffed by family physicians
and RNs who manage triage, labor and delivery, postpartum, and the nursery.
There was an average of 620 births per year from 2000-2003 to Y-K Delta
women. Nearly all (96%) of Y-K Delta women are seen for prenatal care at the
Y-K Delta Regional Hospital, including a prenatal visit at ~36 weeks gestation
(Patten et al., 2008 in press). At this visit, the high-risk pregnancies (about 200
each year) are transferred to the Alaska Native Medical Center in Anchorage.
The remaining women reside at the Bethel pre-maternal home until delivery
and continue to have prenatal checks until delivery. Prenatal providers
routinely asked about tobacco use, but a system is not in place for referring or
treating pregnant women who used tobacco.
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The tobacco educational clinical intervention was piloted in 2002 at the
Nicotine Control and Research Program at the Y-K Delta Regional Hospital.
The Nicotine Control and Research Program provide self-help materials,
face-to-face and telephone counseling, along with physician referrals for
medications to quit tobacco if indicated.
Patients
The educational intervention was piloted over a 10-month period in 2002.
During this time period, 100 Alaska Native pregnant women received the
intervention. There were 549 women seen for their first prenatal visit during
the time period March 1, 2002 through December 31, 2002. Based on our
prior studies examining tobacco use prevalence (Patten et al., 2008 in press),
we conservatively estimate that 50% or 274 of these women were current
tobacco users. Thus, our sample of 100 represents approximately 36% of all
women tobacco users seen for a prenatal visit during the study period.
Intervention
Obstetricians or other health care providers at YKHC identified all
pregnant tobacco users seen for a prenatal visit. If the patient was interested
and willing, she was referred to the Nicotine Control and Research Program
for the intervention. We did not collect data on the number of women
approached. Anecdotal information provided by health care providers
suggests the most common reasons for non-participation were lack of time or
interest.
Four trained, female, Alaska Native, bilingual (English and Yupik) nicotine
dependence counselors in the Nicotine Control and Research Program
delivered the tobacco educational intervention. As part of the clinical
assessment, the counselor conducted a face-to-face interview assessing
socio-demographics, tobacco use, and tobacco-related health beliefs. The
counselor provided advice to stop tobacco use; provided education and
written materials on the effects of tobacco on the woman and her baby;
assessed the woman’s readiness to stop tobacco use; and assisted with
quitting, if desired. A culturally and pregnancy specific brochure “How
Does Tobacco Affect My Baby?” and a clinical teaching sheet “Tobacco and
Pregnancy,” designed by the program staff, were provided to women as part
of the intervention. If the woman indicated she used Iqmik, she was given an
additional brochure entitled “The Dangers of Iqmik Use.” Furthermore, if the
woman was ready to quit tobacco, she was given the brochure entitled “Now
I’m Ready to Quit Nicotine” which described how to quit during pregnancy.
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This intervention is consistent with an evidenced based intervention
recommended for all pregnant tobacco users; i.e., the 5A’s (Melvin et al., 2000;
Fiore et al., 2008).
Procedure
A retrospective review of the clinical database was performed. The
Nicotine Control and Research Program maintain an electronic data base of all
clinical assessments, which was utilized for purposes of this study. Variables
abstracted were socio-demographics, tobacco use characteristics and health
beliefs which are detailed below (see Measures). In addition, data were
abstracted from the woman’s medical record to obtain her tobacco use status
at the last prenatal visit and at delivery.
Measures
Prior to the intervention, the counselor assessed baseline sociodemographics, tobacco use characteristics and tobacco-related health beliefs
using a structured interview.
Socio-demographics.
The counselor assessed the patient’s age; education; duration of this
pregnancy; number of previous pregnancies; primary language; and her
access to a telephone, television, and VCR/DVD in the home or elsewhere.
Tobacco use.
The counselor assessed the type(s) of tobacco used; whether or not the
woman’s home was smoke-free, prior quit attempts, and whether or not
tobacco was used during prior pregnancies. The women were asked the item
“How soon after you first wake up do you first use tobacco?” with response
options: within 5 minutes, 6-30 minutes, 31-60 minutes, or over 60 minutes,
from the Fagerström Tolerance Questionnaire modified for chewers (FTQST) (Boyle, Jensen, Hatsukami, & Severson, 1995; Thomas et al., 2006). We
used the stage of change algorithm (Prochaska & DiClemente, 1992) as a
measure of readiness to quit. Patients were asked “Are you planning to stop
using tobacco for good” with response options: Yes, I’ve already stopped
(action); Yes, I plan to quit today (preparation); Yes, within the next 30 days
(preparation); Yes, within the next 6 months (contemplation); or No, I’m not
planning to stop for good (precontemplation).
Health beliefs.
Drawing from existing validated measures which assess smoking-related
health beliefs of pregnant women (Arnold et al., 2001; Haslam & Draper,
2000), patients were asked “Do you believe that Iqmik is safer to use during
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pregnancy than commercial chew or cigarette smoking? If yes, why?” “Do you
believe tobacco has been harmful to your health? If yes, how?” and “Do you
have any health concerns about your tobacco use for your baby? If yes, what
are these?”
Tobacco use outcomes.
Data were abstracted from the woman’s medical record to obtain
information on the date of the last prenatal visit, date of delivery, tobacco
use status at the last prenatal visit and at delivery, and types of tobacco used
at these time points. Tobacco use status was based on patient self-report to
the obstetrician or other prenatal health care provider as documented in the
medical record. Tobacco use was not biochemically confirmed.
Statistical Methods
Baseline socio-demographics, tobacco use characteristics, and tobaccorelated health belief variables were summarized using mean and standard
deviation (SD) for continuous variables and percentages for categorical
variables. In addition to point estimates, 95% confidence intervals (CI) were
constructed for health beliefs. Analyses were performed to assess whether
the baseline variables differed according to the type of tobacco used at the
time of the intervention, employing Fisher’s exact test for categorical variables
and the Kruskal-Wallis test for continuous variables. Missing values were
not included in denominators for percentages or statistical tests. For these
analyses, type of tobacco used at the time of the intervention was categorized
as Iqmik only, commercial ST use only, cigarette smoking only, or use of
multiple products. The percentage of women abstinent from all tobacco
at the last prenatal visit, and at delivery, was summarized using a point
estimate and 95% CI overall and by type of tobacco used at the time of the
intervention. In all cases, two-sided tests were used with p-values <0.05 used
to denote statistical significance.
The content of the open-ended responses regarding health beliefs (see
Measures) were coded into categories, and subjected to thematic analysis by
the first author. For purposes of triangulation (Lincoln & Guba, 1985), the data
were independently coded and summarized for the major themes by another
investigator. Discrepancies in coding were discussed until consensus was
reached for the major themes.
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Results
Baseline Socio-Demographic and Tobacco Use Characteristics
The 100 pregnant women were from 32 different villages on the Y-K Delta.
Table 1 shows the baseline socio-demographics, tobacco use characteristics,
and tobacco-related health beliefs, overall and by type of tobacco used at
the time of the intervention. The women were on average 25.9±6.2 years of
age (median 25, range 16-42) and were at 6.3± 2.6 months gestation (median
7.9, range 0.7 to 8.9) when seen for the educational intervention. Nearly all
(98%) of the women reported they had a television and VCR/DVD player in
their home, and 98% had a telephone in their home or had access to one. All
currently used tobacco: 56 used Iqmik only, 18 smoked cigarettes only, 13
used commercial ST use only, and 13 reported multiple products. For patients
using multiple products, 6 used Iqmik and commercial ST, 3 used Iqmik and
smoked cigarettes, 3 used commercial ST and smoked cigarettes, and 1 used
all 3 products. None reported current pipe or cigar use. The proportion of
patients who used Iqmik only was higher for those who reported Yupik as
their primary language (86%) compared with those reporting English (14%)
or Cupik (0%) as their first language (p<0.001). No other socio-demographic
characteristics differed significantly by type of tobacco used at the time of the
intervention.
Table 1. Baseline Socio-demographics, Tobacco Use Characteristics, and
Tobacco-Related Health Beliefs by Type of Tobacco Used at the Time of
the Tobacco Educational Intervention among Alaska Native Pregnant
Women (N=100)
			
Variable

Overall
(n=100)

Type of Tobacco Used at Time of Educational Interventiona
Cigarettes
only
(n=18)

Commercial
Iqmik Multiple
p-valueb		
smokeless
only
Products
		
tobacco
(n=56) (n=13)
				
only (n=13)
Socio-demographics 						
Age, mean ± SD
25.9 ± 6.2
25.4 ± 6.2
24.3 ± 4.2
26.7 ± 6.6 25.2 ± 5.9
0.79
median (range)
25 (16-42)
24 (16-42)
25 (19-31)
25 (17-42) 26 (17-36)
Gestation at
intervention,
mean ± SD days 192.5 ± 78 198.9 ± 77.5 208.2 ± 71.9 185.2 ± 81.2 202.5 ± 74.6 0.74
median (range)
240 (22-269) 244 (33-266) 232 (64-269) 235 (22-268) 245 (67-265)
Education,
mean ± SD years 10.2 ± 4.0
10.4 ± 4
10.8 ± 3.3
10.2 ± 4
9.6 ± 4.4
0.71
median (range)
12 (0-15)
12 (0-13)
12 (0-12)
12 (0-15)
11 (0-14)
Primary language						
Yup’ik		
64 (64)
2 (11.1)
8 (61.5)
48 (85.7)
6 (46.2)
<.0001
English
34 (34)
16 (88.9)
4 (30.8)
8 (14.3)
6 (46.2)
Cupik		
2 (2)
0 (0)
1 (7.7)
0 (0)
1 (7.7)
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Variable

Overall
(n=100)

		
				
Telephone in home
If no, access
to telephone

Cigarettes
only
(n=18)

Commercial
smokeless
tobacco
only (n=13)

Iqmik
only
(n=56)

Multiple
Products
(n=13)

p-valueb

94 (94)

16 (88.9)

11 (84.6)

54 (96.4)

4 (66.7)

1 (50)

2 (100)

1 (50)

17 (94.4)

13 (100)

55 (98.2)

0 (0)

--

0 (0)

--

--

14 (77.8)

6 (46.2)

43 (76.8)

9 (69.2)

0.18

2.6 ± 1.9
3 (0-6)

2.2 ± 3.0
0 (0-9)

3.4 ± 3.2
3 (0-14)

3.7 ± 3.4
4 (0-11)

0.50

12 (92.3)

0.556

6 (46.2)
1 (7.7)
5 (38.5)
1 (7.7)

0.24

4 (33.3)
1 (8.3)
2 (16.7)
5 (41.7)

0.57

Television and
VCR/DVD in home 98 (98)
If no, access to
television & VCR/DVD 0 (0)
Reported at least one
previous pregnancy 72 (72)
Number of prior
pregnancies (n=72)
mean ± SD
3.1 ± 3.0
median (range)
3 (0-14)

Tobacco Use Characteristics						
Smoke-free home
89 (89.0)
16 (88.9)
10 (76.9)
51 (91.1)
Readiness to quit tobacco 						
Precontemplation 54 (56.3)
11 (61.1)
4 (36.4)
33 (61.1)
Contemplation
9 (9.4)
0 (0)
2 (18.2)
6 (11.1)
Preparation
30 (31.3)
6 (33.4)
4 (36.4)
15 (27.8)
Action
3 (3.1)
1 (5.6)
1 (9.1)
0 (0)
Tobacco use upon awakening 						
Within 5 minutes 12 (12.5)
2 (11.1)
1 (8.3)
5 (9.3)
6-30 minutes
20 (20.8)
5 (27.8)
4 (33.3)
10 (18.5)
31-60 minutes
18 (18.8)
4 (22.2)
1 (8.3)
11 (20.4)
Over 60 minutes 46 (47.9)
7 (38.9)
6 (50)
28 (51.9)

13 (100)

41

-13 (100)

Prior attempts to stop tobacco use 						
0		
38 (38.4)
6 (33.3)
6 (50)
23 (41.1)
3 (23.1)
1		
21 (21.2)
4 (22.2)
1 (8.3)
12 (21.4)
4 (30.8)
2 or more
40 (40.4)
8 (44.4)
5 (41.7)
21 (37.5)
6 (46.2)
Used tobacco during one or more previous
pregnancies (n=72)c 65 (90.3)
10 (71.4)

3 (50)

0.17
-0.69

0.79

43 (100)

9 (100)

<.0001

Number of previous pregnancies in which tobacco was used (n=65)
mean ± SD
4.0 ± 2.8
3.1 ± 1.7
5.7 ± 2.9
4.0 ± 3.1
median (range)
3 (1-14)
3 (1-6)
4 (4-9)
3 (1-14)

4.4 ± 2.2
5 (1-8)

0.36

Tobacco-Related Health Beliefsd
					
Believes Iqmik is safer to use during
pregnancy
11 (11.1)
2 (11.1)
0 (0)
7 (12.5)
2 (15.4)
Has health concerns about her tobacco use
for her baby
40 (40.4)
8 (44.4)
6 (50)
21 (37.5)
5 (38.5)
Believes tobacco is harmful to her own
health
55 (55.6)
11 (61.1)
6 (50)
29 (51.8)
9 (69.2)

0.67
0.87
0.65

a All values are n (%) except where noted. b P-values obtained using Fisher’s exact test for
categorical variables and Kruskal-Wallis test for continuous variables. Missing values not included
in percentages or statistical tests. c N is based on number of women reporting a previous
pregnancy. d N=99, data on health beliefs were missing for 1 woman.
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About half of the sample (56%) reported they were in the
precontemplation stage of change to stop tobacco use. There was no
statistically significant association detected between patient age and
readiness to quit tobacco (Spearman’s rank correlation, r = -0.04, p = 0.68).
Most (72%) of the women reported at least one previous pregnancy,
with an average of 3 prior pregnancies. Of the 72 women who reported at
least one previous pregnancy, 65 (90%) reported they had used tobacco
during at least one prior pregnancy. There was a significant difference
(p<0.001) in the proportion of women reporting they used tobacco during a
previous pregnancy by type of tobacco used at the time of the intervention
(100% among women who used Iqmik only or multiple tobacco products,
71% among those who smoked cigarettes only and 50% among those who
used commercial ST only). No other tobacco use characteristics differed
significantly by type of tobacco used at the time of the intervention.
Baseline Tobacco-Related Health Beliefs
Only 11% (95% CI 6%-19%) of the women believed Iqmik was safer to use
during pregnancy than other forms of tobacco (see Table 1). Forty percent
(95% CI 31%-51%) reported they had health concerns about their tobacco use
for their baby, and 56% (95% CI 45%-66%) believed that tobacco had been
harmful to their own health. The proportion of women who believed tobacco
was harmful to their own health was significantly higher than the percentage
who believed tobacco use was harmful for their baby (56% vs. 40%, p=0.002).
Thirty-four percent (34/99) of the women indicated no harmful effects for
either self or baby, 25% (25/99) believed tobacco was harmful to self but
not baby, 10% (10/99) reported tobacco was not harmful to self but harmful
for baby, and 30% (30/99) indicated harmful effects for both self and baby.
Tobacco-related health beliefs did not significantly differ by type of tobacco
used at the time of the intervention (Table 1). Table 2 shows results of the
qualitative analysis of concerns women reported about using tobacco for
their own health or for their baby.
Table 2. Themes and Illustrative Quotes of Tobacco-Related Health Beliefs
During Pregnancy
Harmful effects of tobacco use during pregnancy for baby
1. Baby will be born addicted to tobacco
-born addicted
- baby born with withdrawals, jerkiness
- may make baby’s heart beat faster, born with withdrawals
- the nicotine going to the baby

Tobacco Education Intervention for Pregnant Alaska Native Women • Patten et al.

2. Baby will not be healthy
- might be born sickly
- gives baby bad health
- might not grow, low birth weight
- baby might get sick all the time
3. Baby will have lung problems
- less oxygen
- asthma
-my baby’s lungs
- chronic lung disease
Harmful effects of tobacco use during pregnancy for woman’s own health
1. High blood pressure
2. Lung or respiratory problems
-started coughing from cigarettes
-lungs
-breathing, get out of breath
-bronchitis
3. Fatigue
- get tired too easily
- don’t play sports as good as I used to, get tired easily
4. Risk of cancer
-mouth cancer
-can cause cancer and high blood pressure
5. General health
- makes me sick
- dizzy spells
- doctors tell pregnant women not to chew because it harms baby and
mother
6. Appearance related
- yes, my teeth (brown stains)
- yellow teeth
- ruins my teeth
- bad breath
- making skin wrinkle
Tobacco Educational Intervention
The average time counselors spent delivering the intervention was 20.2
± 6.8 minutes (median 20, range 5-45). There was no significant difference
in duration of the intervention by type of tobacco used at the time of the
intervention (p=0.25).
Follow-Up: Tobacco Use at the Last Prenatal Visit and at Delivery
The time from the date the woman was seen for the educational
intervention to the last prenatal visit averaged 72.6 days (median 29.5,
range 0 to 239) and from the last prenatal visit to the time of delivery was
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9.3 days (median 5, range 0 to 152). The mean duration from the date of the
educational intervention to delivery was 77 days (median 30, range 0 to 244).
These time intervals did not differ significantly by type of tobacco used at the
time of the educational intervention.
Table 3 shows the tobacco use status at the last prenatal visit and at
delivery for the 100 women overall and by type of tobacco used at the time
of the educational intervention. At the last prenatal visit, 11% (95% CI 6%19%) reported they did not use any tobacco product. At delivery, 12% (95%
CI 6%-20%) reported abstinence from tobacco. From inspection of Table 3,
there were not substantial changes in type of tobacco used over time. For
example, among the 56 reporting Iqmik only at the time of the educational
intervention, 88% and 87% used Iqmik only at the last prenatal visit and at
delivery, respectively.
Table 3. Tobacco Use at the Last Prenatal Visit and at Delivery by Type of
Tobacco Used at the Time of the Tobacco Educational Intervention among
Alaska Native Pregnant Women (N=100)

			
Variable

Type of Tobacco Used at Time of Educational Interventiona

Overall
(n=100)

		
				

Cigarettes
only
(n=18)

Commercial
smokeless
tobacco
only (n=13)

14 (77.8)

12 (92.3)

Used tobacco at last prenatal
visit 		

89 (89)

Iqmik
only
(n=56)

Multiple
Products
(n=13)

51 (91.1) 12 (92.3)

Type of tobacco use at last prenatal visit 				
None

11 (11)

4 (22.2)

Cigarettes

14 (14)

0.44
<.0001

1 (7.7)

5 (8.9)

1 (7.78)

13 (72.2)

0 (0)

0 (0)

1 (7.7)

Commercial chew 14 (14)

0 (0)

8 (61.5)

2 (3.6)

4 (30.8)

Iqmik 		

61 (61)

1 (5.6)

4 (30.8)

49 (87.5)

7 (53.8)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

51 (91.1)

12 (92.3)

Multiple products

p-valueb		

Used tobacco
at delivery

88 (88)

14 (77.8)

Type of tobacco use at delivery (n=98)
None		

12 (12.2)

4 (22.2)

Cigarettes

14 (14.3)

13 (72.2)

Commercial chew 14 (14.3)
Iqmik 		
Multiple products

11 (84.6)

			
2 (15.4)
0 (0)

0 (0)

9 (69.2)

58 (59.2)

1 (5.6)

2 (15.4)

0 (0)

0 (0)

0 (0)

0.42
<.0001

5 (9.1)

1 (8.3)

0 (0)

1 (8.3)

2 (3.6)

3 (25.0)

48 (87.3) 7 (58.3)
0 (0)

0 (0)

a All values are n (%) except where noted. b P-values derived from Fisher’s exact test.
Missing values are not included in denominators for percentages or statistical tests.
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Discussion
This program evaluation was one step toward developing a tobacco
cessation referral system and intervention that can be routinely implemented
during prenatal care for Alaska Native pregnant women residing in Western
Alaska. Our evaluation of this pilot clinical program addresses a priority
among the Alaska Native people, specifically the health and welfare of
the children (Renner et al., 2004). Together with YKHC and ANTHC, we
committed to a long-term plan to address tobacco use among pregnant
women and children (Enoch & Patten, 2004; Renner et al., 2004). Permanent
implementation of the methods piloted in our educational intervention will
require substantial system and policy changes involving extensive planning
(Windsor, Dalmat, Orleans, & Gritz, 1990; Windsor et al., 2000).
The mean duration of time spent by the counselor with each woman in
our educational intervention was 20 minutes. This supports the feasibility of
delivering a face-to-face tobacco educational intervention at a prenatal visit.
However, even briefer (i.e., 5-10 minutes) interventions at the first prenatal
visit incorporating the 5 A’s have been shown to enhance tobacco abstinence,
and are considered state-of-the art for pregnant women (Fiore et al., 2008;
Melvin et al., 2000; Windsor et al., 2000). Less time-intensive interventions (for
both patients and practitioners) may also allow more women to participate.
Nonetheless, the optimal duration of time needed for effective intervention
needs further study.
The abstinence rates at the last prenatal visit (11%) and at delivery (12%)
were minimal, suggesting the need to augment the tobacco educational
intervention to increase this rate. We did not include a control group and
therefore are not able to characterize the spontaneous rate of cessation in this
population. Among non-Alaska Native pregnant women who report cigarette
smoking at the first prenatal visit, the spontaneous rate of cessation (i.e.,
without treatment) assessed at the end of pregnancy is estimated to be 0%17% (Mullen, 1999; Windsor et al., 1998). Thus, there is a need to identify more
effective interventions for Alaska Native pregnant women. For example, the
intervention could be supplemented with a video or telephone counseling
as we learned that nearly all women had access to a television and DVD/VCR,
and telephone.
Our study also reports new findings on the health beliefs related to
tobacco use during pregnancy that have not been previously reported
for Alaska Native women. Compared with previous studies of non-Alaska
Native pregnant women who smoked cigarettes (Arnold et al., 2001; Dunn
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et al., 1998; Gawley & Cupples, 2002; Lelong et al., 1995; Walsh et al., 1997),
we found a much lower proportion of women who believed that tobacco
was harmful to the fetus (range 61-93% in prior reports vs. 40% in our
study). Moreover, the percentage of women who reported health concerns
about their tobacco use for their baby was significantly lower than for the
proportion indicating concerns for their own health (40% vs. 56%). The
health effects of smoking during pregnancy have been well publicized in the
general U.S. population. Our findings suggest that similar efforts are needed
to educate Alaska Native women about the health effects of tobacco use even
prior to pregnancy. Table 2 offers some insights into concerns women have
that could be emphasized in such educational efforts, but also highlights
areas where education may be helpful, for example, concerns about tobacco
use on pregnancy outcomes were not mentioned.
Unexpectedly, very few (11%) of the women reported they believed that
Iqmik was safer to use during pregnancy than other forms of tobacco. Our
qualitative work (Renner, Enoch et al., 2005; Renner et al., 2004), conducted
during the same time period, indicated a low level of knowledge about the
health risks of Iqmik use during pregnancy. However, it is likely that our
current sample may not be representative of pregnant women in the region.
Selection bias could have occurred if participation varied by education or
knowledge regarding the health risks of tobacco use during pregnancy,
or motivation to quit tobacco use. Those referred and who agreed to
participate may have been more knowledgeable about health risks. Indeed,
our sample represents only about a third of all pregnant tobacco users seen
for a prenatal visit during the pilot intervention period. In addition, we do
not have information on whether or not the prenatal health care provider
told the woman about the risks of tobacco, or Iqmik specifically, prior to
being referred and seen for the educational intervention. Provider education
may have influenced the health beliefs at the time of interview. Related to
this, the women in our sample were seen for the intervention relatively late
in pregnancy and health beliefs may differ earlier in pregnancy. Thus, our
findings on tobacco-related health beliefs should be interpreted within the
context of our sample and the care delivery model.
Another limitation of this study is the small sample size. Moreover,
because this pilot educational intervention was implemented as a clinical
service, we did not obtain biochemical verification of abstinence. As such,
our tobacco abstinence rates may be an overestimate. Based on biochemical
confirmation, the non-disclosure rates of cigarette smoking are as high as 23%
among pregnant women (Windsor et al., 2000). However, our previous pilot
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study with Alaska Native pregnant women (Hurt et al., 2005) found that all
women self-reporting tobacco abstinence were found to have non-detectable
concentrations of serum cotinine (a metabolite of nicotine), confirming the
self-report data. Another drawback is that we did not assess the various
behavioral and pharmacological treatments for tobacco use that patients may
have received subsequent to the educational intervention nor tobacco use
status post-partum.
Recommendations for Future Research
This study suggests several directions for future research. Prior studies
suggest that tobacco-related health beliefs are not highly correlated with
smoking cessation. Because health beliefs were assessed late in pregnancy
and all women continued to use tobacco, we do not know the impact of
health beliefs on cessation in this population. More women had health
concerns about tobacco use during pregnancy for their own health than for
their baby. Perhaps education on the health effects of tobacco use may be
effective as one component of a tobacco cessation intervention, especially
if delivered earlier in pregnancy or even pre-pregnancy. Moreover, the
development, implementation, and evaluation of the feasibility and efficacy
of culturally relevant interventions are needed to enhance the tobacco
abstinence rate. In particular, the results from a treatment efficacy study
could support the basis for a system change in the delivery of a tobacco use
intervention at the first prenatal visit.
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